AR013085A1 - Compuestos derivados de macrolidos c-4'' sustituidos, composicion farmaceutica, metodo de preparacion, compuestos intermediarios para su preparacion - Google Patents
Compuestos derivados de macrolidos c-4'' sustituidos, composicion farmaceutica, metodo de preparacion, compuestos intermediarios para su preparacionInfo
- Publication number
- AR013085A1 AR013085A1 ARP980102704A ARP980102704A AR013085A1 AR 013085 A1 AR013085 A1 AR 013085A1 AR P980102704 A ARP980102704 A AR P980102704A AR P980102704 A ARP980102704 A AR P980102704A AR 013085 A1 AR013085 A1 AR 013085A1
- Authority
- AR
- Argentina
- Prior art keywords
- groups
- preparation
- replaced
- integer ranging
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Un compuesto de formula (I), o una sal farmacéuticamente aceptable del mismo, en la que: X es -CH(NR9R10)-, -C(O)-, C(=NOR9)-, -CH3NR9, o -N(alquiloC1-6)CH2- en los que la primera línea de cada uno de los anteriores grupos X está unida alcar bono C-10 del compuesto de formula (I) y la ultima línea decada grupo está unida al carbono C-8 del compuesto de formula (I); R1 es H, hidroxi o metoxi; R2 es hidroxi; R3 es alquilo C1-10, alquenilo C2-10,alquinilo C2-10, ciano, -CH2S(O)nR8,en e l que n es un numero entero que oscila entre 0 y 2, CH2OR8, -CH2N(OR9)R8, -CH2NR8R15, -(CH2)m(arilo C6-10), o-(CH2)m(heteroarilo de 5-10 elementos), en el que m es un numero entero que oscila de 0 a 4 y en los que los anterioresgrupos R3 están opcionalmentesustituidos con 1 a 3 grupos R16; o R2 y R3 se unen para formar un anillo oxazolilo como se muestra más abajo (formula (II)); R4 es H, -C(O)R9, -C(O)OR9,-C(O)NR9R10 o un grupo protector de hidroxi; R5 es -SR8,-(CH2)nC(O)R8, en el que n es 0 o 1, alquilo C1-10, alquenilo C2-10, alquinilo C2-10,-(CH2)m(ariloC6-10) o -(CH2)m(heteroarilo de 5-10 elementos), en el que m es un numero entero que oscila de 0 a 4, y en los que los grupos R5 anterioresestánopcionalmente sustituidos con grupos 1 a 3 grupos R16; cada R6 y R7 es independientemente H, hidroxi, alcoxi C1-6, alquilo C1-6, alquenilo C2-6,alquinilo C2-6, -(CH2)m(arilo C6-10) o -(CH2)m(heteroarilo de 5-10 elementos), en el que mes un numero entero que oscila de 0 a 4; cada R8 esindependientemente H, alquilo C1-10, alquenilo C2-10, alquinilo C2-10, -(CH2)q CR11R12(CH2)rNR13R14, en el que q y r son cada uno de ellos independientementeun numero entero que oscila de 0 a 3,excepto que q y r no s on ninguno de ellos 0, -(CH2)m(arilo C6-10) o -(CH2)m(heteroarilo de 5-10 elementos), en el
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4998097P | 1997-06-11 | 1997-06-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR013085A1 true AR013085A1 (es) | 2000-12-13 |
Family
ID=21962765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980102704A AR013085A1 (es) | 1997-06-11 | 1998-06-09 | Compuestos derivados de macrolidos c-4'' sustituidos, composicion farmaceutica, metodo de preparacion, compuestos intermediarios para su preparacion |
Country Status (40)
| Country | Link |
|---|---|
| EP (1) | EP0988309B1 (es) |
| JP (1) | JP3262806B2 (es) |
| KR (1) | KR100369959B1 (es) |
| CN (1) | CN1145636C (es) |
| AP (1) | AP1189A (es) |
| AR (1) | AR013085A1 (es) |
| AT (1) | ATE310742T1 (es) |
| AU (1) | AU745006C (es) |
| BG (1) | BG64357B1 (es) |
| BR (1) | BR9810097A (es) |
| CA (1) | CA2293397C (es) |
| CO (1) | CO4950584A1 (es) |
| DE (1) | DE69832486T2 (es) |
| DZ (1) | DZ2515A1 (es) |
| EA (1) | EA002440B1 (es) |
| ES (1) | ES2251081T3 (es) |
| GT (1) | GT199800075A (es) |
| HK (1) | HK1025974A1 (es) |
| HN (1) | HN1998000074A (es) |
| HR (1) | HRP980315A2 (es) |
| HU (1) | HUP0004076A3 (es) |
| ID (1) | ID24530A (es) |
| IL (1) | IL132808A (es) |
| IS (1) | IS1979B (es) |
| MA (1) | MA24563A1 (es) |
| MY (1) | MY133027A (es) |
| NO (1) | NO315560B1 (es) |
| NZ (1) | NZ500652A (es) |
| OA (1) | OA11226A (es) |
| PA (1) | PA8452001A1 (es) |
| PE (1) | PE79999A1 (es) |
| PL (1) | PL337497A1 (es) |
| SK (1) | SK168299A3 (es) |
| TN (1) | TNSN98084A1 (es) |
| TW (2) | TWI224106B (es) |
| UA (1) | UA70298A (es) |
| UY (1) | UY25041A1 (es) |
| WO (1) | WO1998056801A1 (es) |
| YU (1) | YU62999A (es) |
| ZA (1) | ZA985016B (es) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6339063B1 (en) | 1997-09-10 | 2002-01-15 | Merck & Co., Inc. | 9a-azalides as veterinary antimicrobial agents |
| EP1779853A3 (en) * | 1997-09-10 | 2010-01-27 | Merial Ltd. | 9a-azalides as veterinary antimicrobial agents |
| DE69837007T2 (de) * | 1997-09-10 | 2007-11-22 | Merial Ltd. | Verwendung von 9a-azaliden als antimikrobielle mittel für tiere |
| AP9801420A0 (en) * | 1998-01-02 | 1998-12-31 | Pfizer Prod Inc | Novel macrolides. |
| EP1437360A3 (en) * | 1998-08-19 | 2005-04-06 | Pfizer Products Inc. | C11 Carbamates of macrolide antibacterials |
| US6043227A (en) * | 1998-08-19 | 2000-03-28 | Pfizer Inc. | C11 carbamates of macrolide antibacterials |
| US6100240A (en) * | 1998-10-09 | 2000-08-08 | Pfizer Inc | Macrolide derivatives |
| HUP0104192A3 (en) | 1998-11-03 | 2003-12-29 | Pfizer Prod Inc | Novel macrolide antibiotics |
| CA2292359C (en) * | 1999-01-28 | 2004-09-28 | Pfizer Products Inc. | Novel azalides and methods of making same |
| DK1206476T3 (da) * | 1999-08-24 | 2006-05-15 | Abbott Lab | 9a-azalider med antibakteriel virkning |
| US6764996B1 (en) | 1999-08-24 | 2004-07-20 | Abbott Laboratories | 9a-azalides with antibacterial activity |
| PT1250343E (pt) | 2000-01-27 | 2003-11-28 | Pfizer Prod Inc | Composicoes de antibioticos de azalida |
| CA2445306C (en) * | 2001-04-27 | 2008-02-12 | Pfizer Products Inc. | Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
| JP2003040782A (ja) * | 2001-05-31 | 2003-02-13 | Pfizer Prod Inc | アザリド抗生物質組成物 |
| WO2004005313A2 (en) | 2002-07-08 | 2004-01-15 | Pliva - Istrazivacki Institut D.O.O. | Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| EP1521763A2 (en) * | 2002-07-08 | 2005-04-13 | Pliva - Istrazivacki Institut d.o.o. | Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| WO2004005310A2 (en) | 2002-07-08 | 2004-01-15 | Pliva-Istrazivacki Institut D.O.O. | New compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| AR043050A1 (es) | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos |
| US7601695B2 (en) * | 2003-03-10 | 2009-10-13 | Optimer Pharmaceuticals, Inc. | Antibacterial agents |
| US7276487B2 (en) | 2003-09-23 | 2007-10-02 | Enanta Pharmaceuticals, Inc. | 9a, 11-3C-bicyclic 9a-azalide derivatives |
| CN102816194A (zh) | 2004-02-27 | 2012-12-12 | 瑞伯-X医药品有限公司 | 大环化合物以及其制作和使用方法 |
| JPWO2009019868A1 (ja) | 2007-08-06 | 2010-10-28 | 大正製薬株式会社 | １０ａ、１２位架橋型１０ａ−アザライド化合物 |
| CA2703475A1 (en) | 2007-10-25 | 2009-04-30 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
| US8299035B2 (en) | 2008-05-15 | 2012-10-30 | Taisho Pharmaceutucal Co., Ltd. | 10a-azalide compound having 4-membered ring structure |
| CN102245195B (zh) | 2008-10-24 | 2016-01-13 | 森普拉制药公司 | 使用含三唑的大环内酯的生物防御 |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| JP5908479B2 (ja) * | 2010-09-20 | 2016-04-26 | ノバルティス ティーアゲズントハイト アーゲー | クラジノース環のＣ−４”をエポキシド基で修飾した９−デオキソ−９ａ−アザ−９ａ−ホモエリスロマイシンＡの新規製造方法 |
| AR085286A1 (es) | 2011-02-21 | 2013-09-18 | Taisho Pharmaceutical Co Ltd | Derivado de macrolido sustituido en la posicion c-4 |
| EP2830632A4 (en) | 2012-03-27 | 2015-10-21 | Cempra Pharmaceuticals Inc | PARENTERAL FORMULATIONS FOR THE ADMINISTRATION OF MACROLIDE ANTIBIOTICS |
| JP5857008B2 (ja) * | 2012-08-20 | 2016-02-10 | 大正製薬株式会社 | Ｃ−４”位置換マクロライド誘導体を含有する医薬 |
| CN105246334A (zh) | 2013-04-04 | 2016-01-13 | 哈佛大学的校长及成员们 | 大环内酯及其制备和使用方法 |
| CN105669798B (zh) * | 2013-08-23 | 2019-07-26 | 普莱柯生物工程股份有限公司 | 一种大环内酯类化合物 |
| CN103965273B (zh) | 2013-08-23 | 2016-05-25 | 普莱柯生物工程股份有限公司 | 一种大环内酯类化合物 |
| AR102810A1 (es) | 2014-08-18 | 2017-03-29 | Taisho Pharmaceutical Co Ltd | Derivado de macrólido sustituido en la posición c-4 |
| US10633407B2 (en) | 2014-10-08 | 2020-04-28 | President And Fellows Of Harvard College | 14-membered ketolides and methods of their preparation and use |
| JP2018509452A (ja) | 2015-03-25 | 2018-04-05 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 修飾デソサミン糖をもつマクロライドおよびその使用 |
| CN108003207B (zh) | 2017-12-19 | 2019-05-10 | 海门慧聚药业有限公司 | 制备泰拉霉素的方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE445223B (sv) * | 1977-02-04 | 1986-06-09 | Pfizer | Sett att framstella 4"-amino-erytomylin-a-derivat |
| US4150220A (en) * | 1977-02-04 | 1979-04-17 | Pfizer Inc. | Semi-synthetic 4"-erythromycin A derivatives |
| YU43006B (en) * | 1981-03-06 | 1989-02-28 | Pliva Pharm & Chem Works | Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof |
| US4474768A (en) * | 1982-07-19 | 1984-10-02 | Pfizer Inc. | N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor |
| GR80277B (en) * | 1983-09-06 | 1985-01-04 | Pfizer | Azahomoerythromycin b derivatives and intermediates therefor |
| US4512982A (en) * | 1984-04-13 | 1985-04-23 | Pfizer Inc. | 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method |
| CA2064634C (en) * | 1991-04-04 | 1998-08-04 | James V. Heck | 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions |
| US5441939A (en) * | 1994-03-04 | 1995-08-15 | Pfizer Inc. | 3"-desmethoxy derivatives of erythromycin and azithromycin |
| US5412982A (en) * | 1994-03-10 | 1995-05-09 | Potts; James K. | Windsock support |
-
1998
- 1998-05-20 HN HN1998000074A patent/HN1998000074A/es unknown
- 1998-05-22 PA PA19988452001A patent/PA8452001A1/es unknown
- 1998-05-25 HU HU0004076A patent/HUP0004076A3/hu unknown
- 1998-05-25 PL PL98337497A patent/PL337497A1/xx unknown
- 1998-05-25 EP EP98919414A patent/EP0988309B1/en not_active Expired - Lifetime
- 1998-05-25 ES ES98919414T patent/ES2251081T3/es not_active Expired - Lifetime
- 1998-05-25 JP JP50192999A patent/JP3262806B2/ja not_active Expired - Fee Related
- 1998-05-25 NZ NZ500652A patent/NZ500652A/en unknown
- 1998-05-25 BR BR9810097-1A patent/BR9810097A/pt not_active IP Right Cessation
- 1998-05-25 CA CA002293397A patent/CA2293397C/en not_active Expired - Fee Related
- 1998-05-25 ID IDW991565A patent/ID24530A/id unknown
- 1998-05-25 SK SK1682-99A patent/SK168299A3/sk unknown
- 1998-05-25 DE DE69832486T patent/DE69832486T2/de not_active Expired - Fee Related
- 1998-05-25 AT AT98919414T patent/ATE310742T1/de not_active IP Right Cessation
- 1998-05-25 AU AU72281/98A patent/AU745006C/en not_active Ceased
- 1998-05-25 CN CNB988060493A patent/CN1145636C/zh not_active Expired - Fee Related
- 1998-05-25 UA UA99126737A patent/UA70298A/uk unknown
- 1998-05-25 YU YU62999A patent/YU62999A/sh unknown
- 1998-05-25 EA EA199901014A patent/EA002440B1/ru not_active IP Right Cessation
- 1998-05-25 IL IL13280898A patent/IL132808A/en not_active IP Right Cessation
- 1998-05-25 KR KR10-1999-7011643A patent/KR100369959B1/ko not_active IP Right Cessation
- 1998-05-25 WO PCT/IB1998/000799 patent/WO1998056801A1/en not_active Application Discontinuation
- 1998-06-04 AP APAP/P/1998/001254A patent/AP1189A/en active
- 1998-06-08 GT GT199800075A patent/GT199800075A/es unknown
- 1998-06-08 TW TW087109085A patent/TWI224106B/zh active
- 1998-06-08 TW TW093111859A patent/TW200418871A/zh unknown
- 1998-06-08 PE PE1998000469A patent/PE79999A1/es not_active Application Discontinuation
- 1998-06-09 AR ARP980102704A patent/AR013085A1/es active IP Right Grant
- 1998-06-09 MY MYPI98002563A patent/MY133027A/en unknown
- 1998-06-10 CO CO98033231A patent/CO4950584A1/es unknown
- 1998-06-10 MA MA25106A patent/MA24563A1/fr unknown
- 1998-06-10 DZ DZ980125A patent/DZ2515A1/xx active
- 1998-06-10 ZA ZA9805016A patent/ZA985016B/xx unknown
- 1998-06-10 TN TNTNSN98084A patent/TNSN98084A1/fr unknown
- 1998-06-11 HR HR60/049,980A patent/HRP980315A2/hr not_active Application Discontinuation
- 1998-06-11 UY UY25041A patent/UY25041A1/es not_active IP Right Cessation
-
1999
- 1999-11-16 IS IS5250A patent/IS1979B/is unknown
- 1999-12-03 OA OA9900270A patent/OA11226A/en unknown
- 1999-12-08 BG BG103969A patent/BG64357B1/bg unknown
- 1999-12-10 NO NO19996107A patent/NO315560B1/no unknown
-
2000
- 2000-08-28 HK HK00105362A patent/HK1025974A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR013085A1 (es) | Compuestos derivados de macrolidos c-4'' sustituidos, composicion farmaceutica, metodo de preparacion, compuestos intermediarios para su preparacion | |
| AR013086A1 (es) | Compuestos derivados de 9-desoxo-9a-aza-9a-homoeritromicina a c-4 sustituidos, composiciones que los contienen, metodos para preparar los compuestos, uso de dichos compuestos e intermediarios para su preparacion | |
| AR032453A1 (es) | Derivados alquinil fenil heteroaromaticos activadores de glucoquinasa, un proceso para su preparacion, composiciones farmaceuticas, el uso de dichos derivados para la preparacion de medicamentos | |
| AR046297A1 (es) | Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo | |
| AR018634A1 (es) | Derivados de benzo(b)tiepin-1,1,-dioxido, procedimiento para su preparacion, medicamentos conteniendo estos compuestos, procedimiento para la preparacion de medicamentos y su empleo para la preparacion de medicamentos. | |
| AR011093A1 (es) | Compuestos derivados de sulfonil urea, composicion farmaceutica que los contiene y procedimiento para su uso. | |
| AR022303A1 (es) | Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion | |
| AR040806A1 (es) | Derivados de piperidi-2-ona 1,6 disustituidos, composicion farmaceutica que la comprende y metodo de tratamiento | |
| RS49850B (sr) | Derivati 1,4-benzotiazepin-1,1-dioksida supstituisani radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena | |
| AR039673A1 (es) | Derivados de heteroarilamida benzocondensada de tienopiridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos y metodos para su aplicacion | |
| AR017177A1 (es) | Compuesto derivados de 9-amino-3-ceto eritromicina, composiciones farmaceuticas, uso para la preparacion de un medicamento y procedimientos de preparacion. | |
| FR2654104B1 (fr) | Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
| AR035892A1 (es) | Derivados de oxazol, proceso para su preparacion, composiciones farmaceuticas que los comprenden, y el uso de dichos compuestos en la preparacion de medicamentos | |
| AR035235A1 (es) | Derivados heterocicliloxi-,-tioxi- y -aminobenzazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos derivados para la manufactura de un medicamento | |
| AR007759A1 (es) | Nuevos compuestos heterociclicos, el uso de los mismos para preparar composiciones farmaceuticas, un procedimiento para su preparacion ycomposiciones farmaceuticas que los comprenden. | |
| HRP20090629T1 (hr) | Aminoacil-prolijek derivati i lijekovi za liječenje tromboemboličkih poremećaja | |
| MX9307946A (es) | Derivados de amina secundaria ciclica, un procedimiento para su preparacion, composiciones farmaceuticas que los contienen y su uso. | |
| AR005233A1 (es) | Derivados de 1,2,3,4-tetrahidroquinolina, procesos para su preparacion, una composicion farmaceutica y el uso en la elaboracion de un medicamento | |
| AR012436A1 (es) | Compuestos de 4-aminopirido[2,3-d]pirimidina 5,7-disustituidos, composicion farmaceutica que los comprende, el uso de los mismos para lamanufactura de medicamentos, un procedimiento para su preparacion. | |
| PE20020426A1 (es) | ß-TIO-a-AMINOACIDOS, PROCEDIMIENTOS PARA SU PREPARACION Y MEDICAMENTOS QUE LOS CONTIENEN | |
| NO892295D0 (no) | Fremgangsmaate for fremstilling av nye cefemforbindelser. | |
| NO952289L (no) | Substituerte benzazepinoner | |
| ES519491A0 (es) | Un metodo para preparar compuesto de piridilo. | |
| DE69311118D1 (de) | Phosphono-arylethanolamin-verbindungen mit antihyperglykämischer und/oder antiobeser wirkung | |
| AR005347A1 (es) | Compuestos 4,5-di-hidronaf[1,2-c]isoxasoles, derivados y composiciones farmaceuticas, metodo de preparacion, uso como substancia farmaceuticamenteactiva y usos para la fabricacion de medicamentos para el tratamiento de la ansiedad, alteraciones psiquiatricas, nausea, vomitos, dependencia de farmacos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |